EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in the mechanism of the development of hbsag positive and hbsag negative forms of chronic active hepatitis


Klinicheskaya Meditsina (Moscow) 64(11): 73-78
Differences in the mechanism of the development of hbsag positive and hbsag negative forms of chronic active hepatitis
A comparative evaluation was carried out of the quantitative indices and functional activity of cellular and humoral immunity, as well as of the features of the histological and electron microscopic study of liver biopsy specimens of 30 hepatitis patients. T-suppressor cells predominated in the peripheral blood of patients with the HbsAg-positive form of hepatitis. Accumulations of aggressive lymphocytes were found in necrotic foci. Apparently these lymphocytes are T-killers. A pronounced decrease in the amount and functional activity of T-suppressors was observed in patients with the HBsAg-negative form of chronic active hepatitis [CAH]. In HBsAg-positive CAH, the damage to hepatocytes is determined by T-killers and macrophages, but in HBsAg-negative CAH, lymphocytes may be responsible for antibody-dependent cytotoxicity.


Accession: 005151386



Related references

Differences in the mechanism of development of HBsAg-positive and HBsAg-negative forms of chronic active hepatitis. Klinicheskaia Meditsina 64(11): 73-78, 1986

Chronic active hepatitis in Jerusalem: comparison between HBsAg-negative and HBsAg-positive cases. American Journal of Gastroenterology 69(1): 70-80, 1978

In vitro synthesis of IgG and IgM in patients with HBsAg-positive and HBsAg-negative chronic active hepatitis. Liver 3(4): 207-212, 1983

Significance of serum and hepatic markers of hepatitis B viral infection in HBsAg-positive and HBsAg-negative chronic active hepatitis. Hepatology 5(1): 50-53, 1985

HBsAg positive HBsAg negative chronic active hepatitis, liver cirrhosis and hepatocellular carcinoma in Korea: Prevalence and difference in age distribution. Seoul Journal of Medicine 33(2): 127-131, 1992

Early diagnosis and characteristics of the course of HBsAg-positive and HBsAg-negative chronic persistent hepatitis. Klinicheskaia Meditsina 67(2): 73-75, 1989

Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients. Kidney International 28(6): 959-967, 1985

Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease. Journal of Medical Virology 15(4): 351-356, 1985

Long-term efficacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts. Hepatology Research 46(6): 541-551, 2015

Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients. Gut and Liver 5(4): 500-505, 2011